These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9409653)
1. Amino-terminal identity of co-existent amyloid and non-amyloid immunoglobulin kappa light chain deposits. A human disease to study alterations of protein conformation. Kaplan B; Vidal R; Kumar A; Ghiso J; Frangione B; Gallo G Clin Exp Immunol; 1997 Dec; 110(3):472-8. PubMed ID: 9409653 [TBL] [Abstract][Full Text] [Related]
2. Light chain deposition disease derived from the kappa I light chain subgroup. Biochemical characterization. Picken MM; Frangione B; Barlogie B; Luna M; Gallo G Am J Pathol; 1989 Apr; 134(4):749-54. PubMed ID: 2495723 [TBL] [Abstract][Full Text] [Related]
3. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition. Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931 [TBL] [Abstract][Full Text] [Related]
4. ALkappa(I) (UNK) - primary structure of an AL-amyloid protein presenting an organ-limited subcutaneous nodular amyloid syndrome of long duration. Case report and review. Wiegel NM; Mentele R; Kellermann J; Meyer L; Riess H; Linke RP Amyloid; 2010 Mar; 17(1):10-23. PubMed ID: 20146644 [TBL] [Abstract][Full Text] [Related]
5. Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses. Rostagno A; Frizzera G; Ylagan L; Kumar A; Ghiso J; Gallo G Br J Haematol; 2002 Oct; 119(1):62-9. PubMed ID: 12358904 [TBL] [Abstract][Full Text] [Related]
6. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry. Lim A; Wally J; Walsh MT; Skinner M; Costello CE Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain. Hoshii Y; Nanbara H; Cui D; Takahashi M; Ikeda E Med Mol Morphol; 2012 Jun; 45(3):124-8. PubMed ID: 23001294 [TBL] [Abstract][Full Text] [Related]
8. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient. Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188 [TBL] [Abstract][Full Text] [Related]
9. Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR). Odani S; Komori Y; Gejyo F Amyloid; 1999 Jun; 6(2):77-88. PubMed ID: 10439113 [TBL] [Abstract][Full Text] [Related]
10. Shoulder-pad sign of amyloidosis: structure of an Ig kappa III protein. Liepnieks JJ; Burt C; Benson MD Scand J Immunol; 2001 Oct; 54(4):404-8. PubMed ID: 11555407 [TBL] [Abstract][Full Text] [Related]
11. Light chain-associated amyloid deposits comprised of a novel kappa constant domain. Solomon A; Weiss DT; Murphy CL; Hrncic R; Wall JS; Schell M Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9547-51. PubMed ID: 9689117 [TBL] [Abstract][Full Text] [Related]
13. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. Olsen KE; Sletten K; Westermark P Biochem Biophys Res Commun; 1998 Apr; 245(3):713-6. PubMed ID: 9588180 [TBL] [Abstract][Full Text] [Related]
14. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues. Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316 [TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin heavy-chain-associated amyloidosis. Eulitz M; Weiss DT; Solomon A Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650 [TBL] [Abstract][Full Text] [Related]
16. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease. Kaplan B; Livneh A; Gallo G Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908 [TBL] [Abstract][Full Text] [Related]
17. Localized amyloidosis of the larynx: evidence for light chain composition. Berg AM; Troxler RF; Grillone G; Kasznica J; Kane K; Cohen AS; Skinner M Ann Otol Rhinol Laryngol; 1993 Nov; 102(11):884-9. PubMed ID: 8239352 [TBL] [Abstract][Full Text] [Related]
18. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis. Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832 [TBL] [Abstract][Full Text] [Related]
19. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins. Stevens PW; Raffen R; Hanson DK; Deng YL; Berrios-Hammond M; Westholm FA; Murphy C; Eulitz M; Wetzel R; Solomon A Protein Sci; 1995 Mar; 4(3):421-32. PubMed ID: 7795526 [TBL] [Abstract][Full Text] [Related]
20. Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease. Cogné M; Preud'homme JL; Bauwens M; Touchard G; Aucouturier P J Clin Invest; 1991 Jun; 87(6):2186-90. PubMed ID: 1904072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]